| Selected Patient Characteristics and Risk-Adjustment Variables | Prevalence |
|---|---|
| Adverse drug effects | 1,134 (0.49) |
| Age (years) | |
| 18–40 | 95,639 (41.2) |
| 41–60 | 94,978 (40.9) |
| 61–80 | 35,971 (15.5) |
| >80 | 5,584 (2.4) |
| Alcohol or drug abuse | 11,326 (4.9) |
| Anemia | 10,442 (4.5) |
| Body mass index (kg/m2) | |
| <18.5 (underweight) | 3,557 (1.5) |
| 18.5–24.9 (normal) | 67,834 (29.2) |
| 25.0–29.9 (overweight) | 73,852 (31.8) |
| 30.0–34.9 (class I obese) | 39,744 (17.1) |
| 35.0–39.9 (class II obese) | 16,041 (6.9) |
| ≥40.0 (class III obese) | 9,967 (4.3) |
| Missing | 21,177 (9.1) |
| Cataract/aphakia | 4,081 (1.8) |
| Cerebral vascular disease or CVA | 3,612 (1.6) |
| Congestive heart failure | 1,518 (0.7) |
| Depression or anxiety | 50,822 (21.9) |
| Diabetes mellitus | 14,804 (6.4) |
| Ischemic heart disease | 6,007 (2.6) |
| Hepatitis or mononucleosis | 2,356 (1.0) |
| Hyperlipidemia | 65,343 (28.1) |
| Hypertension | 58,849 (25.3) |
| Chronic kidney disease | 2,667 (1.1) |
| Male sex | 101,184 (43.6) |
| Medical or surgical aftercare | 12,871 (5.5) |
| Neoplasm, benign | 26,926 (11.6) |
| Neoplasm, malignant | 3,308 (1.4) |
| Obesity | 16,089 (6.9) |
| Peripheral vascular disease | 1,835 (0.8) |
| Personality disorders | 192 (0.1) |
| Pulmonary disease, chronic obstructive | 3,709 (1.6) |
| Prostatitis/BPH | 7,821 (3.4) |
| Psychosocial problem | 1,463 (0.6) |
| Respiratory tract infection, acute lower | 22,820 (9.8) |
| Respiratory tract infection, acute upper | 47,984 (20.7) |
| Rhinitis, chronic | 49,977 (21.5) |
| Routine health maintenance | 126,419 (54.5) |
| Schizophrenia or affective psychosis | 5,660 (2.4) |
| Visits per year (n) | |
| 1 or 2 | 141,393 (60.9) |
| 3 or 4 | 47,948 (20.7) |
| 5 or 6 | 17,764 (7.7) |
| >6 | 25,067 (10.8) |
Data are n (%).
BPH, benign prostatic hyperplasia; CVA, cerebrovascular accident.